Health · 30 May 2026

NHS cancer blood test trial misses main goal

A big NHS trial of a new blood test for over 50 types of cancer didn't meet its main aim to find late-stage cases earlier. The Galleri test, designed by GRAIL, was given to 142,942 patients over three years, with results shared in Chicago. It aimed to reduce diagnoses at stages three and four, but didn't statistically achieve this.

By BriefTea Editorial · 30 May 2026 at 16:06

Reported by Guardian · How we write briefs

Get the app

Understand this story

What is Blood Cancer UK? What is its main goal?

More briefs

HealthMany NHS Trusts Turn Down Palantir's Patient Data Platform TechnologyRussian Suspect in Deadly London Hospitals Hack Held in Germany HealthGreat Ormond Street's Same-Day Test Finds Hidden Infections in Sick Children HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say More health stories → Browse all stories →